首页> 美国卫生研究院文献>International Journal of Environmental Research and Public Health >Personalized Type 2 Diabetes Management Using a Mobile Application Integrated with Electronic Medical Records: An Ongoing Randomized Controlled Trial
【2h】

Personalized Type 2 Diabetes Management Using a Mobile Application Integrated with Electronic Medical Records: An Ongoing Randomized Controlled Trial

机译:使用与电子医疗记录集成的移动应用程序的个性化2型糖尿病管理:正在进行的随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Controlling type 2 diabetes (T2DM) requires a comprehensive approach including patient education, self-monitoring of blood glucose, individualized behavioral strategies, and frequent contact with healthcare professionals (HCPs). We aimed to compare the efficacy of a personalized lifestyle intervention based on a mobile phone application with regular care in participants with T2DM. This is an ongoing randomized controlled open-label parallel-group trial with a target accrual of 282 participants, of which 181 have been enrolled to date. Participants are randomly assigned to one of three groups: (1) regular care; (2) mobile diabetes management; or (3) mobile diabetes management with HCP feedback. The mobile application is enabled to integrate with both electronic medical records (EMR) and a web-based diabetes management system for HCPs. It can send customized messages based on participants’ responses to lifestyle questionnaires administered at the baseline. The intervention period is 26 weeks followed by observation for 26 weeks. We evaluate the intervention’s features in order to assess its clinical utility and efficacy and compare outcomes with regular care considering relevant clinical factors, such as age, baseline HbA1c, etc. We expect our study to provide new evidence in support of customized mobile application tools for the management of T2DM.
机译:控制2型糖尿病(T2DM)需要一种综合方法,包括患者教育,对血糖的自我监测,个性化行为策略以及与医疗保健专业人士(HCP)的频繁接触。我们旨在比较个性化生活方式干预的效果,基于手机应用,在与T2DM的参与者中定期护理。这是一个正在进行的随机受控开放标签并行组试验,其目标应计数器为282名参与者,其中181名已注册约会。与会者随机分配到三组中的一个:(1)定期护理; (2)移动糖尿病管理;或(3)使用HCP反馈的移动糖尿病管理。移动应用程序能够与电子医疗记录(EMR)和用于HCP的基于Web的糖尿病管理系统集成。它可以根据参与者对基线管理的生活方式问卷的回答发送定制的消息。干预期为26周,然后进行26周的观察。我们评估干预的功能,以评估其临床实用性和疗效,并在考虑相关的临床因素,如年龄,基线HBA1C等的相关临床因素,我们预计我们的研究提供了支持定制的移动应用工具的新证据T2DM的管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号